Movement Alert|Iluvatar CoreX Falls 4.2% in Regular Trading, Stock Connect Inclusion Triggers Sell-the-News Reaction Amid Ongoing Correction

Market Focus
Jun 08

On June 8, Iluvatar CoreX fell 4.2% in regular trading, trading at 478.0 HKD/share, with trading volume of HKD 298 million.

On the news front, the decline is primarily attributed to a classic buy-the-rumor-sell-the-news dynamic. Iluvatar CoreX was officially included in the Shanghai-Shenzhen Stock Connect program effective today, but the market had already fully priced in this catalyst, prompting profit-taking upon realization. The stock had previously surged over 17% from approximately 457 HKD to 537.5 HKD following its inclusion in the Hang Seng Composite Index and an initiation at Outperform rating with a target price of 588.16 HKD. Since May 28, the stock has been in continuous correction, with today's decline extending this technical pullback.

Additionally, cornerstone investor lock-up periods are set to expire in July, with potential unlocking pressure weighing on near-term sentiment. Within the Semiconductors sector, performance is mixed, with Biren Tech up 10.48%, while HUA HONG SEMI down 3.44%, GIGADEVICE down 3.46%, and MONTAGE TECH down 4.12%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10